Sartorius Aktiengesellschaft (ETR:SRT) Shares Up 0.4% - Still a Buy?

Key Points

• Sartorius Aktiengesellschaft shares increased by 0.4%, reaching a last traded price of €149.60 ($173.95) after trading as high as €152.00 ($176.74).
• The company has a market capitalization of $12.68 billion, with a price-to-earnings ratio of 82.09 and a debt-to-equity ratio of 169.56.
• Sartorius provides a variety of bioprocess solutions and lab products, including bioreactors and cell culture media, serving both the U.S. and international markets.

Shares of Sartorius Aktiengesellschaft (ETR:SRT - Get Free Report) shot up 0.4% during mid-day trading on Tuesday . The company traded as high as €152.00 ($176.74) and last traded at €149.60 ($173.95). 7,828 shares traded hands during mid-day trading, The stock had previously closed at €149.00 ($173.26).

Sartorius Aktiengesellschaft Price Performance

The business's 50-day simple moving average is €166.83 and its 200-day simple moving average is €177.85. The stock has a market cap of $12.49 billion, a PE ratio of 80.89, a PEG ratio of 2.28 and a beta of 0.93. The company has a quick ratio of 0.36, a current ratio of 2.02 and a debt-to-equity ratio of 169.56.

Sartorius Aktiengesellschaft Company Profile

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.